Answers are grounded in this paper and cite their sources.
ARVC is a progressive cardiomyopathy requiring early diagnosis, risk stratification, and management strategies including exercise restriction, ICD implantation, and genetic screening.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive cardiomyopathy characterized by fibrofatty infiltration of the myocardium, ventricular arrhythmias, sudden death, and heart failure. ARVC may be an important cause of syncope, sudden death, ventricular arrhythmias, and/or wall motion abnormalities, especially in the young. As the first symptom is sudden death or cardiac arrest in many cases, an early diagnosis and risk stratification are important. Recent advances in diagnostic modalities will be helpful in the early diagnosis and proper management of patients at risk. Restriction of strenuous exercise and implantation of implantable cardioverter-defibrillators are important in addition to medical treatment and catheter ablation of ventricular tachycardia. Recently introduced genetic screening may help to identify asymptomatic carriers with a risk of a disease progression and sudden death.
No takes yet. Share an insight, caveat, or question.
Yongkeun Cho (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: